Inovio Pharmaceuticals
INO
#8916
Rank
โ‚น12.81 B
Marketcap
โ‚น186.52
Share price
-3.29%
Change (1 day)
-5.19%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2025 (TTM): -โ‚น247.77

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -โ‚น260.77. In 2024 the company made an earnings per share (EPS) of -โ‚น357.65 an increase over its 2023 EPS that were of -โ‚น551.41.

EPS history for Inovio Pharmaceuticals from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น247.77-30.72%
2024-โ‚น357.65-35.14%
2023-โ‚น551.41-56.62%
2022-โ‚น1,271-19.54%
2021-โ‚น1,58035.9%
2020-โ‚น1,163-11.57%
2019-โ‚น1,31515.24%
2018-โ‚น1,141-2.78%
2017-โ‚น1,1736.93%
2016-โ‚น1,097134.88%
2015-โ‚น467.21-29.51%
2014-โ‚น662.78-57.34%
2013-โ‚น1,554146.55%
2012-โ‚น630.1920.83%
2011-โ‚น521.53-29.41%
2010-โ‚น738.84-48.48%
2009-โ‚น1,43410%
2008-โ‚น1,30411.11%
2007-โ‚น1,173-41.3%
2006-โ‚น1,999-66.91%
2005-โ‚น6,041110.61%
2004-โ‚น2,868-61.63%
2003-โ‚น7,475186.67%
2002-โ‚น2,608
2001N/A-100%
2000-โ‚น2,086-63.64%
1999-โ‚น5,737

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น155.74-159.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น945.23-462.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-โ‚น113.18-56.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น666.40-355.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
โ‚น687.57-363.67%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น325.59-224.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
โ‚น590.35-326.39%๐Ÿ‡บ๐Ÿ‡ธ USA